,coef,coef_graph,coef_combined,coef_combined_zscore,coef_combined2
Asparagine N-linked glycosylation,0.005057155,4.0,0.005057155,-0.2563709,-0.28814805
RNA Polymerase I Chain Elongation,3.179277e-05,2.0,3.179277e-05,-0.30371615,0.017597014
tRNA processing in the mitochondrion,1.1823356e-07,2.0,1.1823356e-07,-0.30401453,0.017381672
Endosomal Sorting Complex Required For Transport (ESCRT),0.0005296575,2.0,0.0005296575,-0.29902562,0.020981977
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,0.0060759704,2.0,0.0060759704,-0.2467724,0.058690988
Signaling by Interleukins,0.0008415441,12.0,0.0008415441,-0.29608727,-1.6764585
Signaling by NOTCH1,0.025663763,3.0,0.025663763,-0.06223082,0.021911046
Signaling by the B Cell Receptor (BCR),0.0014662931,4.0,0.0014662931,-0.29020134,-0.31256208
Signaling by FGFR in disease,0.0147907315,5.0,0.0147907315,-0.16466841,-0.39192617
Sphingolipid metabolism,0.08434151,3.0,0.08434151,0.49058717,0.42085725
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),0.0014661709,2.0,0.0014661709,-0.2902025,0.027349262
RNA Polymerase II Transcription Elongation,0.52604455,3.0,0.52604455,4.651984,3.4239678
Erythrocytes take up carbon dioxide and release oxygen,0.0007802478,2.0,0.0007802478,-0.29666477,0.022685707
Insulin processing,0.10788508,2.0,0.10788508,0.7123971,0.7508846
Platelet Aggregation (Plug Formation),0.0005505945,2.0,0.0005505945,-0.2988284,0.021124305
Latent infection of Homo sapiens with Mycobacterium tuberculosis,0.0,2.0,0.0,-0.30401567,0.017380854
Rap1 signalling,0.015033201,2.0,0.015033201,-0.16238406,0.11959062
HIV Infection,0.00066024374,3.0,0.00066024374,-0.29779533,-0.14808626
Scavenging by Class H Receptors,0.056516476,2.0,0.056516476,0.22844045,0.40163273
MHC class II antigen presentation,0.011807641,2.0,0.011807641,-0.19277288,0.097660236
Post-translational modification: synthesis of GPI-anchored proteins,0.00037486124,4.0,0.00037486124,-0.300484,-0.31998265
Activation of Matrix Metalloproteinases,0.0009033228,2.0,0.0009033228,-0.29550523,0.023522494
Stimuli-sensing channels,0.023277484,2.0,0.023277484,-0.084712565,0.17564297
Mitochondrial transcription termination,0.005666846,2.0,0.005666846,-0.25062686,0.055909384
Intracellular oxygen transport,1.7444004e-09,2.0,1.7444004e-09,-0.30401567,0.017380854
Metabolism of steroids,0.38657948,6.0,0.38657948,3.3380482,1.9658855
Antimicrobial peptides,0.0016041757,4.0,0.0016041757,-0.2889023,-0.31162465
Interaction With The Zona Pellucida,0.00037164337,2.0,0.00037164337,-0.30051434,0.01990763
Synthesis of IPs in the nucleus,0.0035898355,2.0,0.0035898355,-0.27019492,0.041787922
Cytosolic iron-sulfur cluster assembly,0.005998332,2.0,0.005998332,-0.24750386,0.058163125
NR1D1 (REV-ERBA) represses gene expression,9.6670234e-08,2.0,9.6670234e-08,-0.30401474,0.017381521
"Transport of vitamins, nucleosides, and related molecules",0.002272555,5.0,0.002272555,-0.28260535,-0.47703645
Plasmalogen biosynthesis,0.03973166,2.0,0.03973166,0.070306405,0.28751385
Oncogenic MAPK signaling,0.037998904,7.0,0.037998904,0.053981677,-0.57404745
Butyrophilin (BTN) family interactions,0.003614229,2.0,0.003614229,-0.2699651,0.041953757
Nitric oxide stimulates guanylate cyclase,0.0001225804,2.0,0.0001225804,-0.3028608,0.018214267
tRNA processing in the nucleus,0.0005532467,2.0,0.0005532467,-0.2988034,0.021142349
Nucleotide salvage,0.008961934,3.0,0.008961934,-0.219583,-0.09164362
IPs transport between nucleus and cytosol,0.0,2.0,0.0,-0.30401567,0.017380854
Metabolism of fat-soluble vitamins,0.00507168,4.0,0.00507168,-0.25623408,-0.28804928
SLC transporter disorders,0.004859202,73.0,6.656441e-05,-0.30338857,-12.016463
Electron transport from NADPH to Ferredoxin,0.008655479,2.0,0.008655479,-0.2224702,0.0762289
Interconversion of nucleotide di- and triphosphates,0.013231193,2.0,0.013231193,-0.17936124,0.10733887
Meiotic synapsis,8.361747e-05,2.0,8.361747e-05,-0.30322787,0.017949374
Intra-Golgi and retrograde Golgi-to-ER traffic,0.00036425018,4.0,0.00036425018,-0.30058396,-0.3200548
Reversal of alkylation damage by DNA dioxygenases,0.0017690276,3.0,0.0017690276,-0.28734922,-0.14054772
Signaling by WNT in cancer,0.0038960048,11.0,0.0038960048,-0.2673104,-1.485735
Pre-NOTCH Expression and Processing,0.007524462,4.0,0.007524462,-0.23312579,-0.27137297
RNA Polymerase II Transcription Initiation And Promoter Clearance,0.37284583,3.0,0.37284583,3.20866,2.3823793
Amino acid synthesis and interconversion (transamination),0.008325071,2.0,0.008325071,-0.22558306,0.07398247
Chaperonin-mediated protein folding,0.095068455,4.0,0.095068455,0.59164846,0.32383296
Post-transcriptional silencing by small RNAs,0.0041909977,2.0,0.0041909977,-0.2645312,0.04587519
DNA replication initiation,9.834707e-05,2.0,9.834707e-05,-0.3030891,0.018049506
DDX58/IFIH1-mediated induction of interferon-alpha/beta,0.004456293,6.0,0.004456293,-0.2620318,-0.6321454
p75 NTR receptor-mediated signalling,0.02799583,8.0,0.02799583,-0.040259823,-0.8120139
Scavenging by Class B Receptors,0.0016900924,2.0,0.0016900924,-0.28809288,0.02887169
Biosynthesis of specialized proresolving mediators (SPMs),0.020384558,6.0,0.020384558,-0.11196756,-0.5238502
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,0.04719662,2.0,0.04719662,0.1406357,0.33826762
Basigin interactions,0.07293291,2.0,0.07293291,0.38310382,0.51324695
Integrin cell surface interactions,0.1664771,2.0,0.1664771,1.2644074,1.149248
Transferrin endocytosis and recycling,0.016779115,2.0,0.016779115,-0.14593536,0.13146098
Mitochondrial ABC transporters,1.3205018e-05,2.0,1.3205018e-05,-0.30389124,0.017470643
Amyloid fiber formation,0.021993624,2.0,0.021993624,-0.096808136,0.16691408
Intestinal lipid absorption,8.98108e-06,2.0,8.98108e-06,-0.30393106,0.017441932
Positive epigenetic regulation of rRNA expression,0.013447747,3.0,0.013447747,-0.17732102,-0.061144866
Glycogen metabolism,0.027549332,3.0,0.027549332,-0.044466395,0.034730908
PIP3 activates AKT signaling,0.3043342,5.0,0.3043342,2.5631943,1.5766611
HATs acetylate histones,0.0037909895,2.0,0.0037909895,-0.2682998,0.04315555
Voltage gated Potassium channels,0.0026778819,2.0,0.0026778819,-0.27878666,0.035587613
Sperm:Oocyte Membrane Binding,0.0012572614,2.0,0.0012572614,-0.2921707,0.0259289
NCAM signaling for neurite out-growth,0.00065907795,2.0,0.00065907795,-0.29780632,0.021861885
DNA strand elongation,0.05708868,4.0,0.05708868,0.23383133,0.06561095
ABC transporters in lipid homeostasis,0.0011686442,2.0,0.0011686442,-0.2930056,0.0253264
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),0.00012828042,2.0,0.00012828042,-0.3028071,0.018253021
Fanconi Anemia Pathway,0.0027599437,2.0,0.0027599437,-0.27801353,0.03614555
RNA Polymerase III Transcription Initiation,0.0001279536,4.0,0.0001279536,-0.3028102,-0.32166135
Synthesis of IP3 and IP4 in the cytosol,0.015294621,2.0,0.015294621,-0.15992115,0.121368
trans-Golgi Network Vesicle Budding,0.00013670608,2.0,0.00013670608,-0.30272773,0.018310314
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),0.01463791,2.0,0.01463791,-0.16610819,0.11690306
Cytosolic sensors of pathogen-associated DNA ,0.0050343308,6.0,0.0050343308,-0.25658596,-0.6282154
HSP90 chaperone cycle for steroid hormone receptors (SHR),2.2192304e-05,2.0,2.2192304e-05,-0.3038066,0.017531743
Neurotransmitter release cycle,0.0006857047,7.0,0.0006857047,-0.29755548,-0.8277375
PP2A-mediated dephosphorylation of key metabolic factors,0.0067624585,2.0,0.0067624585,-0.24030483,0.06335837
CDO in myogenesis,0.019731615,2.0,0.019731615,-0.1181191,0.15153483
Ion homeostasis,0.031071285,2.0,0.031071285,-0.011285183,0.22863251
SUMOylation,0.023409056,3.0,0.023409056,-0.083473,0.006581437
Reversible hydration of carbon dioxide,5.989031e-05,2.0,5.989031e-05,-0.30345142,0.017788054
Global Genome Nucleotide Excision Repair (GG-NER),0.03950337,5.0,0.03950337,0.06815563,-0.22390655
PERK regulates gene expression,0.016706709,2.0,0.016706709,-0.14661752,0.13096869
Formation of xylulose-5-phosphate,0.001211312,2.0,0.001211312,-0.29260358,0.025616499
Pyrophosphate hydrolysis,0.00061211246,2.0,0.00061211246,-0.2982488,0.02154258
Transport of inorganic cations/anions and amino acids/oligopeptides,0.005466861,11.0,0.005466861,-0.25251096,-1.4750551
Metallothioneins bind metals,4.6068085e-06,2.0,4.6068085e-06,-0.30397224,0.01741219
Diseases associated with surfactant metabolism,0.065274805,8.0,0.065274805,0.3109549,-0.5585565
C-type lectin receptors (CLRs),0.0046289144,4.0,0.0046289144,-0.26040548,-0.2910596
PKA-mediated phosphorylation of key metabolic factors,0.5325917,2.0,0.5325917,4.7136664,3.6384375
Protein repair,0.035011098,2.0,0.035011098,0.025832798,0.25541905
Cellular hexose transport,0.0047590695,2.0,0.0047590695,-0.25917926,0.049737465
Signaling by TGF-beta Receptor Complex in Cancer,0.0022607434,5.0,0.0022607434,-0.28271663,-0.47711673
mRNA Capping,0.004989907,2.0,0.004989907,-0.25700447,0.051306907
Invadopodia formation,0.0006216917,2.0,0.0006216917,-0.29815856,0.021607703
Digestion of dietary lipid,0.0008416209,2.0,0.0008416209,-0.29608655,0.023102993
Type I hemidesmosome assembly,0.00041960078,2.0,0.00041960078,-0.3000625,0.020233708
Transcriptional activation of mitochondrial biogenesis,0.00080060324,2.0,0.00080060324,-0.296473,0.0228241
Gap junction trafficking and regulation,4.9867875e-05,3.0,4.9867875e-05,-0.30354586,-0.15223618
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",0.013257299,2.0,0.013257299,-0.17911528,0.10751637
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,0.00028805123,2.0,0.00028805123,-0.30130187,0.019339304
tRNA Aminoacylation,0.04573111,3.0,0.04573111,0.12682875,0.15834764
Phase 2 - plateau phase,0.03308715,2.0,0.03308715,0.0077067898,0.24233826
Fructose metabolism,0.0005979814,3.0,0.0005979814,-0.29838195,-0.14850959
Mitotic Spindle Checkpoint,0.052599385,3.0,0.052599385,0.19153653,0.2050446
Translocation of SLC2A4 (GLUT4) to the plasma membrane,6.7811065e-06,2.0,6.7811065e-06,-0.3039518,0.017426964
TNFR2 non-canonical NF-kB pathway,0.015281514,4.0,0.015281514,-0.16004464,-0.21863331
Cargo trafficking to the periciliary membrane,0.012569592,5.0,0.012569592,-0.18559435,-0.40702754
Defective Mismatch Repair Associated With PMS2,0.004995726,2.0,0.004995726,-0.25694966,0.05134648
Uptake and actions of bacterial toxins,0.01035065,5.0,0.01035065,-0.20649956,-0.422114
Integrin alphaIIb beta3 signaling,0.001612981,3.0,0.001612981,-0.28881934,-0.14160869
Growth hormone receptor signaling,0.00020689945,2.0,0.00020689945,-0.30206642,0.01878756
Presynaptic depolarization and calcium channel opening,0.0005601109,2.0,0.0005601109,-0.29873872,0.021189017
Nucleosome assembly,0.016912734,2.0,0.016912734,-0.14467649,0.13236944
CREB3 factors activate genes,0.013730303,2.0,0.013730303,-0.174659,0.110732295
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,0.017309703,2.0,0.017309703,-0.14093655,0.1350684
tRNA modification in the mitochondrion,0.00042375474,2.0,0.00042375474,-0.30002335,0.020261945
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,0.18504481,2.0,0.18504481,1.4393386,1.2754887
Nonhomologous End-Joining (NHEJ),0.013108515,2.0,0.013108515,-0.18051702,0.1065048
Cellular response to heat stress,0.009040875,4.0,0.009040875,-0.21883927,-0.26106298
Sulfur amino acid metabolism,0.002599956,4.0,0.002599956,-0.2795208,-0.30485436
Selenoamino acid metabolism,0.06524797,8.0,0.06524797,0.31070206,-0.558739
PECAM1 interactions,0.00015410697,2.0,0.00015410697,-0.3025638,0.01842862
TNF signaling,0.005455402,5.0,0.005455402,-0.25261894,-0.45539647
Signal regulatory protein family interactions,7.981083e-05,2.0,7.981083e-05,-0.30326375,0.01792348
Lysosomal oligosaccharide catabolism,0.0001413345,2.0,0.0001413345,-0.30268413,0.018341778
ChREBP activates metabolic gene expression,2.6367892e-05,2.0,2.6367892e-05,-0.30376726,0.017560132
Intraflagellar transport,0.000111013884,2.0,0.000111013884,-0.30296978,0.018135639
Telomere Maintenance,0.032429434,3.0,0.032429434,0.0015102902,0.06791041
Fc epsilon receptor (FCERI) signaling,0.016742572,5.0,0.016742572,-0.14627963,-0.3786557
Metabolism of cofactors,0.07318693,4.0,0.07318693,0.385497,0.1750619
IPs transport between cytosol and ER lumen,0.0,2.0,0.0,-0.30401567,0.017380854
Signaling by Retinoic Acid,2.4419405e-05,2.0,2.4419405e-05,-0.30378562,0.017546883
Protein ubiquitination,0.009571367,3.0,0.009571367,-0.2138414,-0.087500125
"Base-Excision Repair, AP Site Formation",0.009789885,3.0,0.009789885,-0.21178268,-0.086014435
Neurotransmitter uptake and metabolism In glial cells,9.428453e-05,2.0,9.428453e-05,-0.3031274,0.018021893
Heme degradation,0.0030719617,2.0,0.0030719617,-0.27507395,0.03826693
mRNA decay by 5' to 3' exoribonuclease,0.007673613,2.0,0.007673613,-0.2317206,0.069553256
Dissolution of Fibrin Clot,0.001189297,2.0,0.001189297,-0.292811,0.025466815
Regulation of gene expression in early pancreatic precursor cells,8.922033e-08,2.0,8.922033e-08,-0.30401483,0.017381458
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",0.000834755,2.0,0.000834755,-0.29615122,0.023056302
Generic Transcription Pathway,0.020414585,11.0,0.020414585,-0.111684665,-1.3734264
Hedgehog 'off' state,0.017816659,4.0,0.017816659,-0.13616039,-0.201397
RNA Polymerase II Transcription Termination,0.019908095,2.0,0.019908095,-0.11645644,0.1527347
Costimulation by the CD28 family,0.0009263055,4.0,0.0009263055,-0.2952887,-0.31623343
Toll-Like Receptors Cascades,0.106231146,10.0,0.106231146,0.696815,-0.62000906
FasL/ CD95L signaling,0.0002489002,2.0,0.0002489002,-0.3016707,0.019073121
GP1b-IX-V activation signalling,4.8970296e-06,2.0,4.8970296e-06,-0.3039695,0.017414168
ESR-mediated signaling,0.020971669,2.0,0.020971669,-0.10643624,0.15996587
Phase I - Functionalization of compounds,0.00022372963,7.0,0.00022372963,-0.30190787,-0.83087844
"Synthesis of IP2, IP, and Ins in the cytosol",0.018583775,2.0,0.018583775,-0.12893319,0.14373073
Scavenging by Class F Receptors,0.0048668496,2.0,0.0048668496,-0.25816384,0.050470248
Eukaryotic Translation Elongation,0.0023928245,2.0,0.0023928245,-0.28147227,0.03364953
Thrombin signalling through proteinase activated receptors (PARs),0.021663968,2.0,0.021663968,-0.09991392,0.16467278
ABC transporter disorders,0.063498326,16.0,0.063498326,0.2942182,-1.9302833
Signaling by PTK6,0.0062253163,10.0,0.0062253163,-0.24536538,-1.2999423
Reelin signalling pathway,0.00035247082,2.0,0.00035247082,-0.30069494,0.019777302
Mitotic G1-G1/S phases,0.044860218,4.0,0.044860218,0.11862387,-0.017529579
G2/M Checkpoints,0.003953324,4.0,0.003953324,-0.2667704,-0.29565293
Fcgamma receptor (FCGR) dependent phagocytosis,0.019512143,4.0,0.019512143,-0.1201868,-0.18986951
SLBP independent Processing of Histone Pre-mRNAs,0.0009141592,2.0,0.0009141592,-0.29540312,0.023596175
Peptide hormone biosynthesis,8.743954e-10,2.0,8.743954e-10,-0.30401567,0.017380854
Meiotic recombination,0.016440958,2.0,0.016440958,-0.14912122,0.12916186
Switching of origins to a post-replicative state,0.11602044,3.0,0.11602044,0.7890425,0.6362403
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.083552085,2.0,0.083552085,0.4831498,0.5854461
Nephrin family interactions,0.00025117732,2.0,0.00025117732,-0.30164927,0.019088605
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,4.698364e-06,2.0,4.698364e-06,-0.3039714,0.017412791
Degradation of beta-catenin by the destruction complex,0.009879623,3.0,0.009879623,-0.21093723,-0.085404314
Triglyceride metabolism,0.0069628907,3.0,0.0069628907,-0.2384165,-0.10523498
Listeria monocytogenes entry into host cells,0.10319134,3.0,0.10319134,0.66817623,0.549016
Signaling by EGFR,0.8533348,6.0,0.8533348,7.735469,5.1393247
Synaptic adhesion-like molecules,0.0004591003,2.0,0.0004591003,-0.29969037,0.020502256
Phase 4 - resting membrane potential,0.007027939,2.0,0.007027939,-0.23780367,0.06516336
Deubiquitination,0.00035752932,6.0,0.00035752932,-0.3006473,-0.66001266
Regulation of Apoptosis,0.003938573,3.0,0.003938573,-0.26690936,-0.12579712
Receptor Mediated Mitophagy,0.0092690205,2.0,0.0092690205,-0.21668985,0.08040033
RHO GTPase Effectors,0.016547227,12.0,0.016547227,-0.14812003,-1.5696764
Pentose phosphate pathway,1.4134639e-06,2.0,1.4134639e-06,-0.30400237,0.017390447
Melanin biosynthesis,4.5228477e-05,2.0,4.5228477e-05,-0.30358955,0.017688373
Collagen biosynthesis and modifying enzymes,0.0053005656,2.0,0.0053005656,-0.25407767,0.053419065
Extrinsic Pathway of Fibrin Clot Formation,0.0027548408,2.0,0.0027548408,-0.2780616,0.03611084
Kinesins,0.011915117,2.0,0.011915117,-0.19176032,0.09839097
Acrosome Reaction,0.0,2.0,0.0,-0.30401567,0.017380854
rRNA processing in the mitochondrion,0.0004284944,2.0,0.0004284944,-0.2999787,0.020294162
Ketone body metabolism,0.0052058967,3.0,0.0052058967,-0.2549696,-0.11718069
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),0.002939977,2.0,0.002939977,-0.2763174,0.037369583
RIPK1-mediated regulated necrosis,0.0005090055,2.0,0.0005090055,-0.2992202,0.02084154
Signaling by FGFR,0.9666593,5.0,0.9666593,8.803128,6.079767
Signaling by Insulin receptor,0.20248769,3.0,0.20248769,1.6036724,1.2241256
Platelet sensitization by LDL,0.0025722934,2.0,0.0025722934,-0.27978143,0.034869734
Platelet calcium homeostasis,0.0007698392,3.0,0.0007698392,-0.29676282,-0.14734113
Abacavir transmembrane transport,1.2159697e-05,2.0,1.2159697e-05,-0.3039011,0.017463526
Laminin interactions,0.005049882,2.0,0.005049882,-0.25643945,0.05171469
Eukaryotic Translation Termination,0.060834486,2.0,0.060834486,0.26912153,0.4309906
Transport of glycerol from adipocytes to the liver by Aquaporins,0.0,2.0,0.0,-0.30401567,0.017380854
Passive transport by Aquaporins,0.011970179,2.0,0.011970179,-0.19124156,0.09876533
Macroautophagy,0.003143585,2.0,0.003143585,-0.27439916,0.03875388
Collagen degradation,0.008884707,2.0,0.008884707,-0.2203106,0.07778739
Synthesis of IPs in the ER lumen,0.0,2.0,0.0,-0.30401567,0.017380854
Diseases associated with visual transduction,0.00049783255,3.0,0.00049783255,-0.29932547,-0.14919049
Lipid particle organization,0.0056635076,2.0,0.0056635076,-0.25065833,0.055886675
rRNA processing in the nucleus and cytosol,0.010203626,3.0,0.010203626,-0.20788471,-0.08320143
Rho GTPase cycle,0.014679919,2.0,0.014679919,-0.1657124,0.117188685
Glycosaminoglycan metabolism,0.06087649,6.0,0.06087649,0.26951724,-0.24854814
"ROS, RNS production in phagocytes",0.0061792005,2.0,0.0061792005,-0.24579985,0.059392847
Signaling by PDGF,0.00030195527,2.0,0.00030195527,-0.30117086,0.019433845
ATF6 (ATF6-alpha) activates chaperones,0.023401488,2.0,0.023401488,-0.08354429,0.17648606
Interaction With Cumulus Cells,0.0,2.0,0.0,-0.30401567,0.017380854
Regulation of signaling by NODAL,7.602096e-05,2.0,7.602096e-05,-0.30329946,0.017897716
Signaling by BMP,0.0069751814,2.0,0.0069751814,-0.23830071,0.064804666
Phase 1 - inactivation of fast Na+ channels,0.002502088,2.0,0.002502088,-0.28044286,0.0343924
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,5.469801e-07,2.0,5.469801e-07,-0.3040105,0.017384576
HCN channels,0.0022979227,2.0,0.0022979227,-0.28236637,0.0330043
mTORC1-mediated signalling,0.00034405087,2.0,0.00034405087,-0.3007743,0.01972003
Heme biosynthesis,0.00825278,2.0,0.00825278,-0.22626412,0.073490985
Recognition of DNA damage by PCNA-containing replication complex,0.045522444,2.0,0.045522444,0.124862865,0.326885
Cell-extracellular matrix interactions,0.0065762307,3.0,0.0065762307,-0.24205932,-0.10786386
Phase 0 - rapid depolarisation,0.011423867,2.0,0.011423867,-0.19638851,0.09505099
Processing of SMDT1,0.069887646,2.0,0.069887646,0.35441363,0.49254245
Phase II - Conjugation of compounds,0.00010363363,7.0,0.00010363363,-0.3030393,-0.8316949
HDACs deacetylate histones,0.022385957,2.0,0.022385957,-0.09311187,0.16958153
DNA Replication Pre-Initiation,0.00078756624,3.0,0.00078756624,-0.29659578,-0.14722061
Eukaryotic Translation Initiation,0.5089685,3.0,0.5089685,4.491106,3.3078685
Erythrocytes take up oxygen and release carbon dioxide,6.2572544e-05,2.0,6.2572544e-05,-0.30342615,0.017806292
Pyruvate metabolism and Citric Acid (TCA) cycle,0.09399549,4.0,0.09399549,0.58153975,0.31653795
EPH-Ephrin signaling,0.00081356737,5.0,0.00081356737,-0.29635087,-0.48695603
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),0.0003019952,2.0,0.0003019952,-0.3011705,0.019434104
DAP12 interactions,0.0005460523,2.0,0.0005460523,-0.29887116,0.021093443
snRNP Assembly,0.07939722,2.0,0.07939722,0.44400573,0.5571974
Defective Mismatch Repair Associated With MSH6,0.0021485917,2.0,0.0021485917,-0.28377324,0.031988986
Cellular Senescence,0.032057233,5.0,0.032057233,-0.001996312,-0.27453235
Apoptotic execution phase,0.01818362,4.0,0.01818362,-0.13270316,-0.19890206
Synthesis of pyrophosphates in the cytosol,0.026636675,2.0,0.026636675,-0.05306477,0.19848189
Rab regulation of trafficking,0.001402203,3.0,0.001402203,-0.29080516,-0.14304174
Transcriptional regulation of white adipocyte differentiation,0.012402663,2.0,0.012402663,-0.18716702,0.10170576
Scavenging of heme from plasma,0.009008575,2.0,0.009008575,-0.21914358,0.07862958
L1CAM interactions,0.0013022146,7.0,0.0013022146,-0.29174718,-0.82354593
Insulin effects increased synthesis of Xylulose-5-Phosphate,0.011003126,2.0,0.011003126,-0.20035242,0.09219039
Branched-chain amino acid catabolism,0.0022959302,2.0,0.0022959302,-0.28238514,0.032990728
TYSND1 cleaves peroxisomal proteins,0.018072622,2.0,0.018072622,-0.13374889,0.14025545
Transcriptional regulation by small RNAs,0.0021891263,2.0,0.0021891263,-0.28339136,0.03226459
Plasma lipoprotein assembly,0.023585701,4.0,0.023585701,-0.08180877,-0.16217364
Signaling by EGFR in Cancer,0.014386399,4.0,0.014386399,-0.16847774,-0.2247191
Signaling by VEGF,0.0049667177,4.0,0.0049667177,-0.25722295,-0.28876293
Aflatoxin activation and detoxification,0.010326356,2.0,0.010326356,-0.20672844,0.087589085
Caspase activation via extrinsic apoptotic signalling pathway,0.058643054,3.0,0.058643054,0.24847548,0.24613513
Diseases associated with O-glycosylation of proteins,0.012996658,10.0,0.012996658,-0.18157084,-1.2539043
Hedgehog 'on' state,0.0005664437,4.0,0.0005664437,-0.29867905,-0.3186801
TCR signaling,0.0072591533,5.0,0.0072591533,-0.23562534,-0.44313288
Diseases associated with glycosaminoglycan metabolism,0.038758352,16.0,0.038758352,0.061136637,-2.0984886
Carboxyterminal post-translational modifications of tubulin,0.0025940589,2.0,0.0025940589,-0.27957636,0.035017695
RMTs methylate histone arginines,0.009584398,2.0,0.009584398,-0.21371862,0.08254456
RET signaling,0.0035073818,2.0,0.0035073818,-0.27097175,0.041227315
Formation of the cornified envelope,0.00013278588,2.0,0.00013278588,-0.30276468,0.018283647
Diseases associated with N-glycosylation of proteins,0.0,17.0,0.0,-0.30401567,-2.5319605
Defective Mismatch Repair Associated With MSH3,0.00015948611,2.0,0.00015948611,-0.3025131,0.018465202
Signaling by NOTCH3,0.05860422,3.0,0.05860422,0.24810962,0.2458711
Neurexins and neuroligins,0.0075716027,2.0,0.0075716027,-0.23268168,0.06885969
Intrinsic Pathway for Apoptosis,0.01261723,8.0,0.01261723,-0.18514553,-0.916572
Advanced glycosylation endproduct receptor signaling,0.00010704523,2.0,0.00010704523,-0.30300716,0.01810865
HDMs demethylate histones,0.0002053064,2.0,0.0002053064,-0.3020814,0.018776743
Galactose catabolism,0.00017540394,2.0,0.00017540394,-0.30236313,0.018573422
Signaling by SCF-KIT,0.0785111,2.0,0.0785111,0.43565735,0.55117273
"Incretin synthesis, secretion, and inactivation",0.00010710632,3.0,0.00010710632,-0.3030066,-0.15184703
Protein methylation,0.0008399154,2.0,0.0008399154,-0.2961026,0.02309138
Netrin-1 signaling,0.0016786912,5.0,0.0016786912,-0.2882003,-0.48107406
Signaling by NOTCH4,0.0010642733,4.0,0.0010642733,-0.29398888,-0.3152954
Mitochondrial translation,0.00061987323,4.0,0.00061987323,-0.2981757,-0.31831685
Diseases associated with glycosylation precursor biosynthesis,0.0,16.0,0.0,-0.30401567,-2.3620043
Effects of PIP2 hydrolysis,2.6615244e-05,2.0,2.6615244e-05,-0.30376494,0.017561808
eNOS activation and regulation,0.0038504335,4.0,0.0038504335,-0.26773974,-0.29635245
Ca2+ activated K+ channels,0.00033953864,2.0,0.00033953864,-0.3008168,0.019689362
Amine-derived hormones,0.0038398951,4.0,0.0038398951,-0.26783904,-0.29642412
PIWI-interacting RNA (piRNA) biogenesis,0.0057914085,2.0,0.0057914085,-0.24945334,0.05675627
Signaling by TGF-beta Receptor Complex,0.023053244,4.0,0.023053244,-0.08682519,-0.16579379
RNA polymerase II transcribes snRNA genes,0.14583343,2.0,0.14583343,1.0699183,1.008893
O-linked glycosylation,0.008167887,3.0,0.008167887,-0.22706392,-0.097042285
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,0.0011550906,2.0,0.0011550906,-0.29313326,0.025234245
AUF1 (hnRNP D0) binds and destabilizes mRNA,0.039877683,2.0,0.039877683,0.07168214,0.28850666
Metabolism of water-soluble vitamins and cofactors,0.13143784,11.0,0.13143784,0.9342937,-0.6185865
GPCR downstream signalling,0.31371337,7.0,0.31371337,2.651558,1.3005174
Signaling by Leptin,0.04802453,2.0,0.04802453,0.14843567,0.34389654
Transport of Mature Transcript to Cytoplasm,0.056616563,3.0,0.056616563,0.2293834,0.23235714
Neurotransmitter clearance,0.00012543211,3.0,0.00012543211,-0.30283394,-0.15172245
Detoxification of Reactive Oxygen Species,0.0010647849,2.0,0.0010647849,-0.29398406,0.024620263
Neutrophil degranulation,0.080551736,2.0,0.080551736,0.45488274,0.5650469
Phenylketonuria,0.0,2.0,0.0,-0.30401567,0.017380854
Beta-catenin independent WNT signaling,0.004778185,3.0,0.004778185,-0.25899917,-0.12008866
Metabolism of polyamines,0.34897238,7.0,0.34897238,2.983742,1.540241
Signaling by ERBB4,0.039333288,5.0,0.039333288,0.06655325,-0.2250629
TRAIL  signaling,0.0012233751,2.0,0.0012233751,-0.29248995,0.025698502
AMPK inhibits chREBP transcriptional activation activity,0.01517527,2.0,0.01517527,-0.16104558,0.12055653
Cell-cell junction organization,0.0060944143,4.0,0.0060944143,-0.24659863,-0.28109577
IPs transport between nucleus and ER lumen,0.0,2.0,0.0,-0.30401567,0.017380854
"Transport of bile salts and organic acids, metal ions and amine compounds",0.0064319815,8.0,0.0064319815,-0.24341834,-0.9586251
Signal amplification,0.025108246,4.0,0.025108246,-0.067464486,-0.15182197
Regulation of insulin secretion,0.049735285,5.0,0.049735285,0.16455312,-0.1543404
RNA Polymerase III Transcription Termination,0.0012620947,2.0,0.0012620947,-0.29212517,0.02596176
Assembly of collagen fibrils and other multimeric structures,8.674534e-06,3.0,8.674534e-06,-0.30393392,-0.15251625
Negative epigenetic regulation of rRNA expression,0.03419711,3.0,0.03419711,0.018164018,0.079928726
Phase 3 - rapid repolarisation,0.00041937034,2.0,0.00041937034,-0.30006468,0.020232137
DNA methylation,0.015808566,2.0,0.015808566,-0.15507914,0.124862276
Phospholipid metabolism,0.27045196,3.0,0.27045196,2.2439811,1.68621
Signaling by MST1,0.017604437,2.0,0.017604437,-0.13815978,0.13707228
Signaling by ERBB2,0.047243,9.0,0.047243,0.14107266,-0.8511097
mRNA Splicing,0.07896063,3.0,0.07896063,0.4398925,0.384273
Pink/Parkin Mediated Mitophagy,0.0024815958,2.0,0.0024815958,-0.28063592,0.034253083
Platelet Adhesion to exposed collagen,3.076892e-05,2.0,3.076892e-05,-0.3037258,0.017590046
Deadenylation of mRNA,0.7466166,2.0,0.7466166,6.7300496,5.093579
mRNA 3'-end processing,0.097517654,2.0,0.097517654,0.61472297,0.6803971
Nucleobase biosynthesis,0.008519588,3.0,0.008519588,-0.22375046,-0.0946511
Response to elevated platelet cytosolic Ca2+,0.15254042,3.0,0.15254042,1.1331065,0.8845373
Abacavir metabolism,0.028973753,2.0,0.028973753,-0.031046567,0.21437153
Lactose synthesis,0.00031756866,2.0,0.00031756866,-0.30102375,0.01954
Class I MHC mediated antigen processing & presentation,0.004316515,4.0,0.004316515,-0.2633487,-0.2931836
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,0.0019120757,2.0,0.0019120757,-0.2860015,0.030380938
WNT ligand biogenesis and trafficking,0.051874373,2.0,0.051874373,0.184706,0.37007138
Post-translational protein phosphorylation,0.0017032119,2.0,0.0017032119,-0.28796926,0.028960878
ER to Golgi Anterograde Transport,0.0008946212,4.0,0.0008946212,-0.2955872,-0.31644884
Electric Transmission Across Gap Junctions,0.0028490631,2.0,0.0028490631,-0.27717394,0.03675145
Neddylation,0.010238171,2.0,0.010238171,-0.20755926,0.08698952
IPs transport between ER lumen and cytosol,0.0,2.0,0.0,-0.30401567,0.017380854
Common Pathway of Fibrin Clot Formation,0.019508896,2.0,0.019508896,-0.12021739,0.15002058
RNA Pol II CTD phosphorylation and interaction with CE,0.026370231,2.0,0.026370231,-0.055575006,0.19667034
Energy dependent regulation of mTOR by LKB1-AMPK,0.00041046616,2.0,0.00041046616,-0.30014855,0.020171598
RNA Polymerase III Chain Elongation,0.0004029012,2.0,0.0004029012,-0.30021983,0.020120155
Tie2 Signaling,0.0017421925,2.0,0.0017421925,-0.28760204,0.0292259
RNA Polymerase I Transcription Termination,0.0005239198,2.0,0.0005239198,-0.2990797,0.020942964
SRP-dependent cotranslational protein targeting to membrane,0.015249307,2.0,0.015249307,-0.16034806,0.12105992
Inwardly rectifying K+ channels,0.0036005345,5.0,0.0036005345,-0.27009413,-0.46800762
Signaling by NOTCH2,0.018910514,3.0,0.018910514,-0.1258549,-0.02400386
Processing of Intronless Pre-mRNAs,0.002169621,2.0,0.002169621,-0.28357512,0.03213196
Molecules associated with elastic fibres,0.0068727587,2.0,0.0068727587,-0.23926567,0.0641083
Scavenging by Class A Receptors,0.020745082,2.0,0.020745082,-0.10857097,0.15842533
PRC2 methylates histones and DNA,0.00040424173,2.0,0.00040424173,-0.3002072,0.020129273
Post-chaperonin tubulin folding pathway,0.0028172617,2.0,0.0028172617,-0.27747354,0.036535244
Neurotransmitter receptors and postsynaptic signal transmission,0.0019277331,6.0,0.0019277331,-0.285854,-0.64933693
Cristae formation,0.0035442386,2.0,0.0035442386,-0.2706245,0.041477907
Interferon Signaling,0.0012944001,4.0,0.0012944001,-0.2918208,-0.31373078
Defects in vitamin and cofactor metabolism,0.012592466,3.0,0.012592466,-0.18537885,-0.066959865
Miscellaneous transport and binding events,0.00029832704,2.0,0.00029832704,-0.30120504,0.019409178
IPs transport between ER lumen and nucleus,0.0,2.0,0.0,-0.30401567,0.017380854
DAG and IP3 signaling,0.007203808,2.0,0.007203808,-0.23614676,0.06635909
Striated Muscle Contraction,0.019001447,2.0,0.019001447,-0.124998204,0.14657046
"Synthesis, secretion, and deacylation of Ghrelin",0.023308307,2.0,0.023308307,-0.08442217,0.17585252
KSRP (KHSRP) binds and destabilizes mRNA,0.0146162305,2.0,0.0146162305,-0.16631244,0.11675566
IP3 and IP4 transport between cytosol and nucleus,0.0,2.0,0.0,-0.30401567,0.017380854
Inhibition of TSC complex formation by PKB,0.0016664524,2.0,0.0016664524,-0.2883156,0.028710954
G1/S DNA Damage Checkpoints,0.0047720396,3.0,0.0047720396,-0.25905707,-0.12013045
Complement cascade,0.00047226992,5.0,0.00047226992,-0.2995663,-0.4892765
MGMT-mediated DNA damage reversal,0.0027403804,2.0,0.0027403804,-0.27819785,0.03601251
Signaling by MET,0.00640247,9.0,0.00640247,-0.24369636,-1.1287818
Tandem pore domain potassium channels,0.011517185,7.0,0.011517185,-0.19550933,-0.75409496
Mitochondrial protein import,0.0006827048,2.0,0.0006827048,-0.29758373,0.022022516
Sperm Motility And Taxes,0.00014467107,2.0,0.00014467107,-0.3026527,0.018364467
RNA Polymerase I Promoter Clearance,0.011826556,4.0,0.011826556,-0.19259468,-0.24212332
Glyoxylate metabolism and glycine degradation,8.375187e-05,2.0,8.375187e-05,-0.30322662,0.017950276
Signaling by NTRKs,1.129318,5.0,1.129318,10.335577,7.185673
HuR (ELAVL1) binds and stabilizes mRNA,0.00805203,2.0,0.00805203,-0.22815545,0.072126076
Metabolism of Angiotensinogen to Angiotensins,0.0056610852,2.0,0.0056610852,-0.25068113,0.055870224
tRNA modification in the nucleus and cytosol,1.5243214e-05,2.0,1.5243214e-05,-0.30387205,0.017484494
IRE1alpha activates chaperones,0.00043415913,2.0,0.00043415913,-0.29992533,0.02033268
Choline catabolism,0.011079594,2.0,0.011079594,-0.19963199,0.092710294
DNA Double Strand Break Response,0.005754131,3.0,0.005754131,-0.24980453,-0.11345326
Clathrin-mediated endocytosis,0.0007099437,2.0,0.0007099437,-0.2973271,0.022207728
"Gamma carboxylation, hypusine formation and arylsulfatase activation",0.019242112,5.0,0.019242112,-0.122730836,-0.36166152
Mitotic G2-G2/M phases,0.013724954,3.0,0.013724954,-0.1747094,-0.059260152
Wax biosynthesis,8.512455e-05,2.0,8.512455e-05,-0.30321372,0.017959611
Fatty acid metabolism,0.02375975,7.0,0.02375975,-0.08016901,-0.6708585
Diseases associated with the TLR signaling cascade,6.576511e-08,12.0,6.576511e-08,-0.30401504,-1.6821795
IP6 and IP7 transport between cytosol and nucleus,0.0,2.0,0.0,-0.30401567,0.017380854
TCF dependent signaling in response to WNT,0.009685689,10.0,0.009685689,-0.21276434,-1.2764155
Diseases of carbohydrate metabolism,0.0035967587,8.0,0.0035967587,-0.27012968,-0.9779016
"TET1,2,3 and TDG demethylate DNA",0.0003033691,2.0,0.0003033691,-0.30115756,0.019443437
Intestinal hexose absorption,1.1081489e-08,2.0,1.1081489e-08,-0.30401558,0.01738094
Surfactant metabolism,0.00019030744,2.0,0.00019030744,-0.30222273,0.018674739
Signaling by ROBO receptors,0.0005256904,9.0,0.0005256904,-0.299063,-1.1687376
RAB geranylgeranylation,0.0013138558,2.0,0.0013138558,-0.2916375,0.026313689
Defective Mismatch Repair Associated With MSH2,0.00021402715,2.0,0.00021402715,-0.30199927,0.018835992
MTF1 activates gene expression,0.0042405957,2.0,0.0042405957,-0.26406395,0.04621239
Homology Directed Repair,0.04791866,3.0,0.04791866,0.14743821,0.17322065
RORA activates gene expression,5.4230994e-05,2.0,5.4230994e-05,-0.30350474,0.01774958
Metabolic disorders of biological oxidation enzymes,0.0016580698,33.0,5.024454e-05,-0.30354232,-5.2399845
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,0.016186595,6.0,0.016186595,-0.15151763,-0.5523918
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",0.023904873,4.0,0.023904873,-0.07880177,-0.16000362
Vasopressin regulates renal water homeostasis via Aquaporins,0.023841241,2.0,0.023841241,-0.07940126,0.1794759
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.016542418,3.0,0.016542418,-0.14816533,-0.040104385
Plasma lipoprotein remodeling,0.026177023,5.0,0.026177023,-0.057395272,-0.3145115
RNA Polymerase III Abortive And Retractive Initiation,0.0006298931,2.0,0.0006298931,-0.29808128,0.021663468
Digestion of dietary carbohydrate,0.01138433,2.0,0.01138433,-0.196761,0.09478218
Signaling by Hippo,0.042990047,2.0,0.042990047,0.10100452,0.3096674
Transcription-Coupled Nucleotide Excision Repair (TC-NER),0.07466651,4.0,0.07466651,0.3994365,0.18512146
Small interfering RNA (siRNA) biogenesis,0.00024748856,2.0,0.00024748856,-0.301684,0.019063529
Activation of anterior HOX genes in hindbrain development during early embryogenesis,0.013968848,2.0,0.013968848,-0.17241159,0.112354144
Hh mutants abrogate ligand secretion,0.010743941,3.0,0.010743941,-0.20279425,-0.079527855
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.004530928,2.0,0.004530928,-0.26132864,0.048186347
"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism",0.0025811687,6.0,0.0025811687,-0.27969784,-0.64489424
Cellular response to hypoxia,9.848008e-05,2.0,9.848008e-05,-0.30308786,0.018050432
Anchoring of the basal body to the plasma membrane,0.0006050058,2.0,0.0006050058,-0.29831576,0.021494256
Receptor-type tyrosine-protein phosphatases,0.009176808,2.0,0.009176808,-0.21755861,0.079773396
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",0.0066195102,2.0,0.0066195102,-0.24165158,0.06238648
Glucagon signaling in metabolic regulation,0.037038516,2.0,0.037038516,0.044933625,0.26920334
RNA Polymerase II Pre-transcription Events,0.07913281,2.0,0.07913281,0.4415147,0.5553997
Smooth Muscle Contraction,0.0416003,2.0,0.0416003,0.08791137,0.3002186
Plasma lipoprotein clearance,2.7407557e-05,6.0,2.7407557e-05,-0.30375746,-0.66225713
Prostacyclin signalling through prostacyclin receptor,0.078351706,2.0,0.078351706,0.4341557,0.55008906
Influenza Infection,0.07599276,3.0,0.07599276,0.4119315,0.36409467
mRNA decay by 3' to 5' exoribonuclease,0.13247763,2.0,0.13247763,0.9440898,0.91808766
ECM proteoglycans,0.13902552,2.0,0.13902552,1.0057791,0.9626065
Ion transport by P-type ATPases,0.059382405,2.0,0.059382405,0.2554411,0.421118
Hedgehog ligand biogenesis,0.00013491487,2.0,0.00013491487,-0.3027446,0.018298142
Prolactin receptor signaling,0.0014867508,2.0,0.0014867508,-0.2900086,0.02748918
mRNA Editing: C to U Conversion,0.00051986176,2.0,0.00051986176,-0.29911792,0.02091535
Semaphorin interactions,0.00075266673,6.0,0.00075266673,-0.29692462,-0.65732616
GPCR ligand binding,0.044555586,4.0,0.044555586,0.11575385,-0.019600753
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),0.0002585514,2.0,0.0002585514,-0.3015798,0.019138714
Defective Mismatch Repair Associated With MLH1,0.0016109791,2.0,0.0016109791,-0.2888382,0.028333798
LGI-ADAM interactions,0.00010749026,2.0,0.00010749026,-0.30300298,0.018111682
Signaling by NOTCH1 in Cancer,0.0053498014,6.0,0.0053498014,-0.25361383,-0.6260705
M Phase,0.027336435,5.0,0.027336435,-0.04647215,-0.30662873
Physiological factors,6.6513436e-05,2.0,6.6513436e-05,-0.303389,0.01783309
MicroRNA (miRNA) biogenesis,0.004241782,2.0,0.004241782,-0.26405278,0.046220455
Regulation of gene expression in beta cells,0.00014724213,2.0,0.00014724213,-0.30262846,0.018381951
MAPK6/MAPK4 signaling,0.19061066,2.0,0.19061066,1.4917759,1.3133305
S Phase,0.0067210034,4.0,0.0067210034,-0.24069539,-0.27683565
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",0.0010757513,2.0,0.0010757513,-0.29388073,0.024694825
Signaling by Activin,0.025818093,2.0,0.025818093,-0.06077684,0.1929164
Threonine catabolism,0.0013199875,2.0,0.0013199875,-0.29157972,0.026355369
Regulation of mitotic cell cycle,0.004819066,2.0,0.004819066,-0.25861403,0.050145376
Mitochondrial transcription initiation,0.0060271937,2.0,0.0060271937,-0.24723195,0.058359362
Resolution of Abasic Sites (AP sites),0.028533284,5.0,0.028533284,-0.035196338,-0.29849145
MAPK1/MAPK3 signaling,0.010657141,3.0,0.010657141,-0.20361203,-0.08011801
mRNA Editing: A to I Conversion,0.002558982,3.0,0.002558982,-0.27990684,-0.13517688
PI3K/AKT Signaling in Cancer,0.042053737,4.0,0.042053737,0.09218329,-0.036610663
PKMTs methylate histone lysines,0.0029533666,2.0,0.0029533666,-0.27619123,0.037460618
GPVI-mediated activation cascade,0.014686791,2.0,0.014686791,-0.16564767,0.1172354
Nucleobase catabolism,0.008806759,4.0,0.008806759,-0.22104496,-0.26265472
Syndecan interactions,0.00020584013,2.0,0.00020584013,-0.3020764,0.018780354
Intrinsic Pathway of Fibrin Clot Formation,0.0073226793,2.0,0.0073226793,-0.23502684,0.06716728
Glucose metabolism,0.022217104,3.0,0.022217104,-0.094702676,-0.001522566
Fibronectin matrix formation,0.0,2.0,0.0,-0.30401567,0.017380854
